<DOC>
	<DOC>NCT01451710</DOC>
	<brief_summary>This is a single center,prospective,no-controlled clinical trial</brief_summary>
	<brief_title>The Effectiveness of Enough Steroids as Inducement Therapy in Minimal Change Disease-like IgA Nephropathy</brief_title>
	<detailed_description>1. The complete remission of enough steroids as inducement therapy in adult minimal change disease-like IgA nephropathy patients 2. The safety of enough steroids as inducement therapy in adult minimal change disease-like IgA nephropathy patients</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Glomerulonephritis, IGA</mesh_term>
	<mesh_term>Nephrosis, Lipoid</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Prednisone</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>Female or male patients aged between 18 to 65 years Renal biopsy was used to diagnose IgA nephropathy Patients with 24h proteinuria 3.5g and serum albumin concentration lower than 30g/L Patients with serum creatinine â‰¥ 3 mg/dl or eGFR &lt; 30ml/min per 1.73 m2 urine RBC &gt; 1 million/ml Patients who have received treatment of enough steroids for more than 12 weeks patients with secondary IgA Patients who have impaired liver function,with ALT/GPT or AST/GOT twice more than the normal upper limit or who have active hepatitis Patients with 2 type diabetes or obesity, whose BMI is more than 28kg/m2</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>enough steroids</keyword>
	<keyword>MCD</keyword>
	<keyword>efficacy</keyword>
</DOC>